Dr Reddy’s Debuts Daraprim Rival In US
Also Introduces Naloxone With CGT Exclusivity And First Generic Ziprasidone
Dr Reddy’s has launched the first generic version of Daraprim in the US. The company has also introduced naloxone with 180 days of exclusivity under the FDA’s Competitive Generic Therapy pathway, as well as the first US generic of ziprasidone mesylate.
